Literature DB >> 18521289

Local excision without radiation for high-grade soft-tissue sarcoma of the extremity and superficial trunk.

L M Weir1, A B Vanbergeyk, B A Masri, C A Grafton, C P Duncan, K J Goddard, H A Joe.   

Abstract

Purpose. Limb-sparing surgery combined with radiation treatment has become the accepted treatment for patients with high-grade soft-tissue sarcoma. Adjuvant radiation was not routinely used at this institution for patients with clear margins after surgery.This retrospective review analyses the outcome of this group of patients.Patients and methods. Patients studied were referred from 1984 to 1995, were over 16 years of age, were diagnosed with primary high-grade soft-tissue sarcoma of the extremity or superficial trunk, had clear margins after excision and did not receive radiation as a part of their initial treatment. A total of 46 patients were identified.Results. At 5 years, the local control rate was 87%, disease-specific survival was 75% and overall survival was 68%. Of the 6 local recurrences, 3 were located in the buttock (from a total of 7 patients with primary tumours of the buttock), 3 had a primary size of >/= 10 cm (from a total of 8 primary tumours of that size) and all were deep tumours.Discussion. Our data, and those from other reports, suggest that in carefully selected patients appropriate surgery alone results in acceptable local control and survival, and that the morbidity of radiation can be avoided.

Entities:  

Year:  2000        PMID: 18521289      PMCID: PMC2395434          DOI: 10.1080/13577140020008075

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  18 in total

Review 1.  The epidemiology of soft tissue sarcoma.

Authors:  S H Zahm; J F Fraumeni
Journal:  Semin Oncol       Date:  1997-10       Impact factor: 4.929

2.  Treatment of the patient with stage M0 soft tissue sarcoma.

Authors:  H D Suit; H J Mankin; W C Wood; M C Gebhardt; D C Harmon; A Rosenberg; J E Tepper; D Rosenthal
Journal:  J Clin Oncol       Date:  1988-05       Impact factor: 44.544

3.  Surgery without radiotherapy in soft tissue sarcoma.

Authors:  A Rydholm
Journal:  Acta Orthop Scand Suppl       Date:  1997-02

4.  Local control and survival in soft tissue sarcomas of the limbs, trunk walls and head and neck: a study of 113 cases.

Authors:  J S Abbatucci; N Boulier; J de Ranieri; A M Mandard; A Tanguy; J C Vernhes; J C Lozier; A Busson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038

5.  Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection.

Authors:  H T Barkley; R G Martin; M M Romsdahl; R Lindberg; G K Zagars
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-04       Impact factor: 7.038

6.  The management of soft-tissue sarcomas of the extremities.

Authors:  M A Simon; W F Enneking
Journal:  J Bone Joint Surg Am       Date:  1976-04       Impact factor: 5.284

7.  Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

Authors:  J C Yang; A E Chang; A R Baker; W F Sindelar; D N Danforth; S L Topalian; T DeLaney; E Glatstein; S M Steinberg; M J Merino; S A Rosenberg
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

8.  Soft tissue sarcoma of the extremity. Limb salvage after failure of combined conservative therapy.

Authors:  C Catton; A Davis; R Bell; B O'Sullivan; V Fornasier; J Wunder; M McLean
Journal:  Radiother Oncol       Date:  1996-12       Impact factor: 6.280

9.  Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity.

Authors:  W C Williard; S I Hajdu; E S Casper; M F Brennan
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

10.  Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma.

Authors:  S F Stinson; T F DeLaney; J Greenberg; J C Yang; M H Lampert; J E Hicks; D Venzon; D E White; S A Rosenberg; E J Glatstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-11       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.